Lanean...
Biologics in inflammatory bowel disease: what are the data?
BACKGROUND: Over the last decade, biologics have gained an important place for the treatment of moderate to severe inflammatory bowel disease (IBD), and many randomized control trials have evaluated their efficacy. AIM: The goal of this review is to analyze the results of these trials and to highlig...
Gorde:
| Argitaratua izan da: | United European Gastroenterol J |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625751/ https://ncbi.nlm.nih.gov/pubmed/26535119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615590302 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|